WallStSmart
AVTR

Avantor Inc

NYSE: AVTR · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$8.10
+3.18% today

Updated 2026-04-30

Market cap
$5.35B
P/E ratio
P/S ratio
0.82x
EPS (TTM)
$-0.78
Dividend yield
52W range
$7 – $16
Volume
9.5M

Avantor Inc (AVTR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$636.90M$691.30M$1.25B$5.86B$6.04B$6.39B$7.39B$4.91B$6.97B$6.78B$6.55B
Revenue growth (YoY)+8.5%+80.4%+370.1%+3.0%+5.8%+15.5%-33.5%+41.9%-2.6%-3.4%
Cost of revenue$374.70M$371.60M$814.60M$4.04B$4.12B$4.31B$4.88B$2.31B$4.60B$4.50B$4.41B
Gross profit$262.20M$319.70M$432.80M$1.82B$1.92B$2.08B$2.50B$2.60B$2.36B$2.28B$2.14B
Gross margin41.2%46.2%34.7%31.0%31.8%32.5%33.9%53.0%33.9%33.6%32.7%
R&D$21.90M$19.10M
SG&A$185.20M$309.80M$643.20M$1.41B$1.37B$1.37B$1.53B$1.47B$1.51B$1.64B$1.60B
Operating income$60.30M$9.90M$-210.40M$413.50M$551.80M$706.80M$972.20M$1.13B$696.40M$1.08B$-246.20M
Operating margin9.5%1.4%-16.9%7.1%9.1%11.1%13.2%23.0%10.0%16.0%-3.8%
EBITDA$121.10M$70.00M$-160.10M$814.60M$879.50M$765.30M$1.35B$1.53B$1.10B$1.48B$138.70M
EBITDA margin19.0%10.1%-12.8%13.9%14.6%12.0%18.3%31.3%15.8%21.8%2.1%
EBIT$60.40M$9.70M$-259.30M$410.00M$480.60M$369.90M$970.40M$1.13B$695.30M$1.07B$-271.50M
Interest expense$0.00$80.30M$200.90M$523.80M$440.00M$307.60M$217.40M$265.80M$284.80M$218.80M$169.80M
Income tax$17.10M$10.10M$-314.90M$-26.90M$2.80M$-54.30M$180.40M$-164.60M$89.40M$142.40M$88.90M
Effective tax rate44.2%-31.3%73.6%23.6%6.9%-87.2%24.0%-31.5%21.8%16.7%-20.1%
Net income$21.60M$-42.40M$-112.70M$-86.90M$37.80M$116.60M$572.60M$686.50M$321.10M$711.50M$-530.20M
Net income growth (YoY)-296.3%-165.8%+22.9%+143.5%+208.5%+391.1%+19.9%-53.2%+121.6%-174.5%
Profit margin3.4%-6.1%-9.0%-1.5%0.6%1.8%7.8%14.0%4.6%10.5%-8.1%